MedElevator
Войти в исследования Indian heart journal · 2025
Cardinal aspects of treatment to control hypertension in India-2022 (CATCH 22): A survey on arterial hypertension management in young Indian adults: A report from cardiology society of India.
СтатьяМногоцентровое исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Roy Debabrata, Naik Nitish, Kumar Dilip, Mantoo Mohsin Raj, Banerjee P S, Srivastava Punit, Bang Vijay Harikisan, Rath Pratap Chandra, Yadav Rakesh, Asokan P K, Sinha D P
Аннотация
BACKGROUND: India has a high burden of premature cardiovascular disease, with early-onset hypertension being a key driver. However, real-world data on hypertension management in young Indian adults remain limited.
OBJECTIVES: To evaluate physician practices in diagnosing and treating hypertension among Indian adults aged 18-45 years, with a focus on guideline concordance, lifestyle interventions, and comorbidity-specific treatment choices.
METHODS: A nationwide, web-based survey of 3,289 physicians was conducted from December 2022 to August 2023 using a 22-point questionnaire. An additional module collected anonymized data on 8,195 hypertensive patients. Analyses included descriptive statistics and logistic regression to assess factors associated with BP control (<130/80 mmHg).
RESULTS: Most physicians (66 %) managed over five young hypertensive patients monthly. While lifestyle advice was commonly given (>80 %), no structured programs or adherence tracking were used. Monotherapy was initiated in 49 % of cases, with β-blockers prescribed in 32 %, despite guidelines favoring dual therapy with ARBs, ACE inhibitors, or CCBs. Only 27 % of physicians reported BP control in >50 % of their patients. Among patients, 65 % achieved target BP; 34.6 % had target organ damage. Positive predictors of BP control included male gender, private-sector care, and fruit/vegetable intake, while longer disease duration and target organ damage were associated with poorer control.
CONCLUSIONS: Hypertension management in young Indian adults shows substantial deviations from global guidelines. Overuse of monotherapy, β-blockers, and lack of structured lifestyle support underscore the need for practice transformation to improve long-term cardiovascular outcomes.
OBJECTIVES: To evaluate physician practices in diagnosing and treating hypertension among Indian adults aged 18-45 years, with a focus on guideline concordance, lifestyle interventions, and comorbidity-specific treatment choices.
METHODS: A nationwide, web-based survey of 3,289 physicians was conducted from December 2022 to August 2023 using a 22-point questionnaire. An additional module collected anonymized data on 8,195 hypertensive patients. Analyses included descriptive statistics and logistic regression to assess factors associated with BP control (<130/80 mmHg).
RESULTS: Most physicians (66 %) managed over five young hypertensive patients monthly. While lifestyle advice was commonly given (>80 %), no structured programs or adherence tracking were used. Monotherapy was initiated in 49 % of cases, with β-blockers prescribed in 32 %, despite guidelines favoring dual therapy with ARBs, ACE inhibitors, or CCBs. Only 27 % of physicians reported BP control in >50 % of their patients. Among patients, 65 % achieved target BP; 34.6 % had target organ damage. Positive predictors of BP control included male gender, private-sector care, and fruit/vegetable intake, while longer disease duration and target organ damage were associated with poorer control.
CONCLUSIONS: Hypertension management in young Indian adults shows substantial deviations from global guidelines. Overuse of monotherapy, β-blockers, and lack of structured lifestyle support underscore the need for practice transformation to improve long-term cardiovascular outcomes.